DoxyPEP: Opportunities for Expansion.
DoxyPEP: Opportunities for Expansion. J Prim Care Community Health. 2025 Jan-Dec; 16:21501319251370497.
PMID: 40913480
A 26-Year-Old Woman with Postpartum Abdominal Pain.
A 26-Year-Old Woman with Postpartum Abdominal Pain. NEJM Evid. 2025 Feb; 4(2):EVIDmr2400398.
PMID: 39873543
Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban Tanzania.
Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban Tanzania. J Antimicrob Chemother. 2024 01 03; 79(1):36-45.
PMID: 37935111
Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban Tanzania.
Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban Tanzania. J Antimicrob Chemother. 2023 Nov 03.
PMID: 37935111
Transfusion-Transmitted Cache Valley Virus Infection in a Kidney Transplant Recipient With Meningoencephalitis.
Transfusion-Transmitted Cache Valley Virus Infection in a Kidney Transplant Recipient With Meningoencephalitis. Clin Infect Dis. 2023 02 08; 76(3):e1320-e1327.
PMID: 35883256
Role of Therapeutic Drug Monitoring in the Treatment of Persistent Mycobacterium abscessus Central Nervous System Infection: A Case Report and Review of the Literature.
Role of Therapeutic Drug Monitoring in the Treatment of Persistent Mycobacterium abscessus Central Nervous System Infection: A Case Report and Review of the Literature. Open Forum Infect Dis. 2022 Aug; 9(8):ofac392.
PMID: 35983263
Disparities in COVID-19 Monoclonal Antibody Delivery: a Retrospective Cohort Study.
Disparities in COVID-19 Monoclonal Antibody Delivery: a Retrospective Cohort Study. J Gen Intern Med. 2022 08; 37(10):2505-2513.
PMID: 35469360
Reply to Lapadula et al.
Reply to Lapadula et al. Clin Infect Dis. 2022 01 29; 74(2):363-364.
PMID: 34015090
Real-World Experience of Bamlanivimab for Coronavirus Disease 2019 (COVID-19): A Case-Control Study.
Real-World Experience of Bamlanivimab for Coronavirus Disease 2019 (COVID-19): A Case-Control Study. Clin Infect Dis. 2022 01 07; 74(1):24-31.
PMID: 33846730